Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by M101


PMN

could have been us, 10 years ago.

Traventis inks preclinical deal with Takeda.  Small molecule tau drug...

April 11, 2023

PMN

RE:IND

Here we go!! but first sell on news!! Here we go!! only 2 qtrs late!! Here we...

April 10, 2023

PMN

RE:RE:Looking for a new director

goldtech wrote: Good start, now to get rid of Williams, Kirwin, Wyman and a...

April 10, 2023

PMN

RE:Entered Into The Game

Lol, so close to your 30 day expectation. I see nothing interesting in...

April 10, 2023

PMN

RE:RE:PMN looking better

Yeah, mushy, a P1 not to hit the target but to adjust the focal distance...

April 5, 2023

PMN

last week for 30

Re the 60 day clock started Mar 08, bball 67 wrote " My guess is...

April 3, 2023

PMN

RE:Phase 1 looking good for Lilly except the usual problem

Reminds me of the old door to door salesman who were incapable of hearing the...

March 31, 2023

PMN

RE:Ghathat the 2nd Promis Mole says Phenomenal data!!!!!

Phenomenal? I should hope so, that's the whole point of branding for...

March 31, 2023

PMN

RE:New Preclinical Data

bball67 wrote: So, Promis put out a press release on March 13th saying they...

March 29, 2023

PMN

RE:M101, your take on the latest news release?

My beef was always with the spin not the science and the new poster headline...

March 29, 2023

PMN

RE:Biomarkers

It is a key question for IR, but I would put it this way: which biomarker(s...

March 24, 2023

PMN

RE:Alzheimers assocation fights back regulators

Such brave, selfless crusaders for truth, justice and humanity.  Please...

March 21, 2023

PMN

RE:RE:Who is selling?

The bank failure is hurting all microcaps, see the 10-day  https://www...

March 20, 2023

PMN

RE:Who is selling?

This is the price of the unexplained quarter delay as compared to last year...

March 20, 2023

PMN

shades of grey

“Furthermore, it is important to emphasize that correlation between a...

March 20, 2023

PMN

RE:Great discussion on AD treatments

Great discussion? Mentions lifestyle and diet in the context of healthy...

March 20, 2023

PMN

vitamin D/AD study continues, not that pharma would notice

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12404 Dr John...

March 14, 2023

PMN

I want to believe

"Differentiation of PMN310 from Other Amyloid-Beta-Directed Antibodies...

March 13, 2023

PMN

RE:M101 in the PR

Thanks for the reply Betty, I'll admit that my bar for success has...

March 10, 2023

PMN

good luck with that

https://endpts.com/eisai-projects-7b-in-sales-by-2030-for-new-alzheimers-drug...

March 10, 2023

Featured Company